Unichem Labs gets USFDA nod for hypertension drug Guanfacine
Mumbai: Drugmaker, Unichem Laboratories Limited, has recently announced that the company has received abbreviated new drug application (ANDA) approval for its Guanfacine Tablets, USP 1 mg and 2 mg from the United States Food and Drug Administration (USFDA) to market a generic version of TENEX (Guanfacine) Tablets 1 mg and 2 mg of Promius Pharma LLC.
Guanfacine Tablets are indicated in the management of hypertension.
The product will be commercialized from Unichem's Ghaziabad Plant.
Read also: Unichem Labs plaque psoriasis drug Apremilast gets USFDA nod
Unichem Laboratories Limited is an international, integrated, specialty pharmaceutical company.
It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in several markets across the world.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd